torsemide has been researched along with angiotensin ii in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayashi, K; Kido, H; Uchida, T; Watanabe, M | 1 |
Deger, F; Douchamps, J; Herchuelz, A; Staroukine, M; van Ganse, E; Verniory, A | 1 |
Beck, FX; Müller, E; Ohno, A; Pfaller, W; Seppi, T | 1 |
Díez, J; Fortuño, A; Fortuño, MA; Muñiz, P; Ravassa, S; Rodriguez, JA; Zalba, G | 1 |
Díez, J; Fortuño, A; Fortuño, MA; Muñiz, P; Zalba, G | 1 |
Schenk, H; Schlesinger, S; Spies, C; von Dossow, V; von Heymann, C | 1 |
Arutiunov, GP; Dragunov, DO; Sokolova, AV | 1 |
2 trial(s) available for torsemide and angiotensin ii
Article | Year |
---|---|
Secondary pulmonary hypertension: haemodynamic effects of torasemide versus furosemide.
Topics: Administration, Oral; Aged; Angiotensin II; Antihypertensive Agents; Cardiac Output; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Endothelin-1; Female; Furosemide; Hemodynamics; Humans; Hypertension, Pulmonary; Injections, Intravenous; Lung; Male; Middle Aged; Pilot Projects; Prospective Studies; Stroke Volume; Sulfonamides; Torsemide; Treatment Outcome | 2008 |
[Effect of loop diuretics with different elimination half-lives on natriuresis changes and indicators characterizing the state of renal tubulointerstitial tissue].
Topics: Adult; Angiotensin II; Chronic Disease; Delayed-Action Preparations; Female; Half-Life; Heart Failure; Humans; Hypertension; Kidney Tubules; Male; Middle Aged; Natriuresis; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide | 2014 |
5 other study(ies) available for torsemide and angiotensin ii
Article | Year |
---|---|
Diuretic action of the novel loop diuretic torasemide in the presence of angiotensin II or endothelin-1 in anaesthetized dogs.
Topics: Acute Kidney Injury; Anesthesia; Angiotensin II; Animals; Blood Pressure; Diuretics; Dogs; Endothelins; Female; Furosemide; Glomerular Filtration Rate; Insulin; Loop of Henle; Male; Potassium; Renal Circulation; Sodium; Sulfonamides; Torsemide; Urodynamics | 1992 |
Failure of indomethacin to impair the diuretic and natriuretic effects of the loop diuretic torasemide in healthy volunteers.
Topics: Adult; Angiotensin II; Creatinine; Diuresis; Diuretics; Humans; Indomethacin; Male; Natriuresis; Renin; Sodium; Sulfonamides; Torsemide | 1986 |
Inhibition of angiotensin-converting enzyme modulates structural and functional adaptation to loop diuretic-induced diuresis.
Topics: Aldosterone; Anesthesia; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Consciousness; Diuresis; Diuretics; Electrolytes; Enalapril; Hematocrit; Kidney Cortex; Kidney Function Tests; Kidney Tubules; Male; Rats; Rats, Wistar; Rubidium; Sodium; Sodium-Potassium-Exchanging ATPase; Sulfonamides; Torsemide; Urine; Vasoconstrictor Agents; Water-Electrolyte Balance | 1997 |
Torasemide inhibits angiotensin II-induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Biphenyl Compounds; Calcium; Cells, Cultured; Endothelium, Vascular; Furosemide; Hypertension; Intracellular Membranes; Irbesartan; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Sulfonamides; Tetrazoles; Torsemide; Vasoconstriction | 1999 |
Effects of loop diuretics on angiotensin II-stimulated vascular smooth muscle cell growth.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Biphenyl Compounds; Carrier Proteins; Cell Division; Cells, Cultured; Chlorides; Diuretics; Furosemide; Irbesartan; Leucine; Loop of Henle; Muscle, Smooth, Vascular; Potassium; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium; Sodium-Potassium-Chloride Symporters; Sulfonamides; Tetrazoles; Thymidine; Torsemide | 2001 |